http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107647952-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2240-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2240-001
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00736
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14
filingDate 2017-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107647952-B
titleOfInvention A kind of amnion lacrimal passage recovery support and its manufacturing method
abstract The present invention provides a kind of amnion lacrimal passage recovery support, including amnion rack body made of the amnion freeze-dried processing, the suture at amnion rack body both ends, the length of the bigger suture therebetween of the length of the amnion rack body between two suture nodes are connected to one.Amnion lacrimal passage recovery support of the invention, when traction, amnion rack body does not stress, it is ensured that amnion lacrimal passage recovery support will not be broken in lacrimal passage, it is readily adapted to accommodate the curved structure of lacrimal passage, it avoids causing damage and adhesion due to drawing friction to lacrimal passage tissue and causing secondary blocking, while amnion rack body has good therapeutic efficiency to pathological tissues, is conducive to the recovery of lacrimal passage epithelial structure and function, prevent scar from being formed, efficient high, long-term effect is good, and recurrence rate is low;It can voluntarily degrade after the implantation of amnion rack body, be taken out without operation again;It long-term preservation, convenient transportation can meet clinical needs at any time at normal temperature.
priorityDate 2017-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-204193131-U
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452794181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448365594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23662274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21917771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81646

Total number of triples: 39.